Walleye Capital LLC Raises Stake in Maximus, Inc. $MMS

Key Points

• Walleye Capital LLC increased its holdings in Maximus, Inc. by 162.3% in Q1, owning 134,743 shares valued at approximately $9.2 million.
• Additionally, a number of hedge funds have also increased their positions, with 97.21% of Maximus's stock now owned by institutional investors.
• Maximus declared a quarterly dividend of $0.30 per share, reflecting an annualized yield of 1.4%, to be paid to shareholders on August 31.

Walleye Capital LLC lifted its stake in Maximus, Inc. (NYSE:MMS - Free Report) by 162.3% during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 134,743 shares of the health services provider's stock after buying an additional 83,373 shares during the quarter. Walleye Capital LLC owned approximately 0.24% of Maximus worth $9,188,000 at the end of the most recent reporting period.

Several other hedge funds have also recently modified their holdings of MMS. Caitong International Asset Management Co. Ltd lifted its holdings in shares of Maximus by 17,533.3% in the first quarter. Caitong International Asset Management Co. Ltd now owns 529 shares of the health services provider's stock worth $36,000 after buying an additional 526 shares in the last quarter. UMB Bank n.a. lifted its holdings in shares of Maximus by 70.2% in the first quarter. UMB Bank n.a. now owns 606 shares of the health services provider's stock worth $41,000 after buying an additional 250 shares in the last quarter. GAMMA Investing LLC lifted its holdings in shares of Maximus by 67.1% in the first quarter. GAMMA Investing LLC now owns 732 shares of the health services provider's stock worth $50,000 after buying an additional 294 shares in the last quarter. NBC Securities Inc. increased its position in Maximus by 114,900.0% in the first quarter. NBC Securities Inc. now owns 1,150 shares of the health services provider's stock worth $78,000 after purchasing an additional 1,149 shares during the last quarter. Finally, Blue Trust Inc. increased its position in Maximus by 32.8% in the first quarter. Blue Trust Inc. now owns 1,228 shares of the health services provider's stock worth $84,000 after purchasing an additional 303 shares during the last quarter. Hedge funds and other institutional investors own 97.21% of the company's stock.

Maximus Trading Up 0.4%

MMS stock traded up $0.34 during mid-day trading on Friday, reaching $88.06. 434,573 shares of the stock traded hands, compared to its average volume of 677,149. The company has a debt-to-equity ratio of 0.91, a quick ratio of 2.27 and a current ratio of 2.27. Maximus, Inc. has a one year low of $63.77 and a one year high of $93.94. The stock has a market capitalization of $4.96 billion, a PE ratio of 16.22 and a beta of 0.61. The business has a 50-day moving average price of $76.35 and a two-hundred day moving average price of $71.70.

Maximus (NYSE:MMS - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The health services provider reported $2.16 earnings per share for the quarter, beating analysts' consensus estimates of $1.39 by $0.77. Maximus had a net margin of 5.83% and a return on equity of 24.44%. The business had revenue of $1.35 billion for the quarter, compared to analysts' expectations of $1.29 billion. During the same quarter in the previous year, the business posted $1.74 earnings per share. The business's revenue was up 2.5% compared to the same quarter last year. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. Equities research analysts expect that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Sunday, August 31st. Shareholders of record on Friday, August 15th will be given a dividend of $0.30 per share. The ex-dividend date is Friday, August 15th. This represents a $1.20 dividend on an annualized basis and a yield of 1.4%. Maximus's payout ratio is 22.10%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on MMS shares. Wall Street Zen cut shares of Maximus from a "buy" rating to a "hold" rating in a research report on Thursday, May 15th. Zacks Research upgraded shares of Maximus from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, August 26th. One research analyst has rated the stock with a Strong Buy rating and one has issued a Buy rating to the company's stock. According to MarketBeat, Maximus has an average rating of "Strong Buy" and a consensus price target of $90.00.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.